Back to search

Article

Development of a machine learning model to predict short duration HCV treatment response

2025-09-22

Abstract excerpt

<h4>Background</h4> Standard durations of direct acting antivirals (DAAs; 8–12 weeks) can be a barrier to HCV treatment initiation and completion among marginalised populations. This study developed a machine learning model to predict short-duration (4–6 weeks) DAA response using baseline clinical factors with potential to improve treatment uptake, cost-effectiveness and health system efficiency. <h4>Methods</h4>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
edcef26f-2b06-5254-9135-a6368e5e6899
DOI
10.1101/2025.09.19.25336147
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of a machine learning model to predict short duration HCV treatment responseDOI 10.1101/2025.09.19.25336147
Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysisSemantic proximity
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.Semantic proximity
Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.Semantic proximity
Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy: A National Observational Cohort StudySemantic proximity
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.Semantic proximity
Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience.Semantic proximity
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationSemantic proximity
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study.Semantic proximity
Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.Semantic proximity
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.Semantic proximity
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for Hepatitis C: a single arm mechanistic pilot studySemantic proximity
Real-World Validation of Machine Learning Models for HIV Treatment Adherence Prediction and Care Gap Quantification: A Multi-Country Analysis of 192,732 Clinical RecordsSemantic proximity
Select a neighboring publication to make it the new centre.